Progression of Atypical Endometrial Hyperplasia to Adenocarcinoma Despite Intrauterine Progesterone Treatment With the Levonorgestrel-Releasing Intrauterine System
- 1 February 2008
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 111 (2), 547-549
- https://doi.org/10.1097/01.aog.0000300716.84819.c6
Abstract
Intrauterine progesterone therapy has been proposed as a potential uterine-sparing treatment for atypical endometrial hyperplasia and adenocarcinoma. We present a case of an infertility patient with atypical endometrial hyperplasia who was treated with the levonorgestrel-releasing intrauterine system for 6 months. At follow-up, she was noted to have an increasing endometrial thickness on ultrasonography, and biopsy revealed progression of her lesion to adenocarcinoma. Although there is a need for uterine-sparing treatment for atypical endometrial hyperplasia and early adenocarcinoma, especially in the setting of desired fertility, caution should be exercised. We do not recommend using the levonorgestrel-releasing intrauterine system as a treatment for atypical hyperplasia or adenocarcinoma until further studies demonstrate the efficacy of this treatment.Keywords
This publication has 6 references indexed in Scilit:
- Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-upMaturitas, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasiaCancer, 2006
- Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literatureGynecologic Oncology, 2005
- Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancerObstetrics & Gynecology, 2003
- Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40Obstetrics & Gynecology, 1997